Sever Pharma Solutions Appoints Fredrik Hultenius as New CEO
Sever Pharma Solutions, a leading Contract Development and Manufacturing Organization (CDMO) specializing in controlled release systems for high potent drugs, with manufacturing facilities in Malmö, Sweden and Putnam, CT USA, is pleased to announce the appointment of Fredrik Hultenius as its new Chief Executive Officer, effective July 1st, 2025.
Fredrik has been a vital member of the Sever Pharma Solutions team since 2021, initially leading production and site operations in Malmö before advancing to Vice President of Operations with global responsibilities.
Fredrik brings over a decade of valuable experience in the pharmaceutical and medical device industries, previously holding key roles at Baxter International and Tetra Pak. His extensive background underscores his proven ability to manage teams, drive operational efficiency, and foster continuous improvement.
“We are excited about the leadership and operational expertise Fredrik brings to the role of CEO,” said Sean Davis, CEO of Sever Life Science. “His ability to lead teams, collaborate effectively with external partners, and drive strategic business development will be pivotal in achieving our ambitious growth goals.”
Fredrik holds an M.Sc. in Production Engineering and a B.Sc. in Mechanical Engineering, credentials which further strengthen his ability to guide Sever Pharma Solutions through its next growth phase.
Please join us in congratulating Fredrik Hultenius and wishing him great success in his new position.
